Brendan Frett - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Brendan Frett

Showing results (51-60 of 54) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 54 results.

The Journal of Clinical Investigation|September 2, 2020

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2Jia Wang, Peng Cheng, Marat S Pavlyukov, et al.

The Journal of Clinical Investigation|October 12, 2020

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2Jia Wang, Peng Cheng, Marat S Pavlyukov, et al.

The Journal of Clinical Investigation|July 25, 2017

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2Jia Wang, Peng Cheng, Marat S Pavlyukov, et al.

Molecular Cancer Therapeutics|October 10, 2023

Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in LymphomaMason McCrury, Kennith Swafford, Sydnye L Shuttleworth, et al.

Pageof 6

Search research articles

Showing results (51-60 of 54) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 54 results.

The Journal of Clinical Investigation|September 2, 2020

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2Jia Wang, Peng Cheng, Marat S Pavlyukov, et al.

The Journal of Clinical Investigation|October 12, 2020

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2Jia Wang, Peng Cheng, Marat S Pavlyukov, et al.

The Journal of Clinical Investigation|July 25, 2017

Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2Jia Wang, Peng Cheng, Marat S Pavlyukov, et al.

Molecular Cancer Therapeutics|October 10, 2023

Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in LymphomaMason McCrury, Kennith Swafford, Sydnye L Shuttleworth, et al.

Pageof 6